英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - dichlorobenzyl alcohol; amylmetacresol - lozenge - 1.2mg ; 600microgram

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

omega pharma ltd - nicotine - lozenge - 2mg

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

omega pharma ltd - nicotine - lozenge - 4mg

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - flumazenil 0.1 mg/ml - solution for injection - 0.5 mg/5ml - active: flumazenil 0.1 mg/ml excipient: acetic acid disodium edetate dihydrate nitrogen sodium chloride sodium hydroxide water for injection - flumazenil injection is indicated for reversal of the centrally sedative effects of benzodiazepines. it should therefore be used in anaesthesia and intensive care in the following indications: in anaesthesia · termination of general anaesthesia induced and maintained with benzodiazepines in inpatients. · reversal of benzodiazepine sedation in short diagnostic and therapeutic procedures in both inpatients and outpatients. · reversal of paradoxical reactions due to benzodiazepines. in intensive care and in the management of unconsciousness of unknown origin · for the diagnosis and/or management of benzodiazepine overdose due to self-poisoning or accidental overdose. · as a diagnostic measure in unconsciousness of unknown origin to differentiate between involvement of benzodiazepines, other medicines or drugs or brain damage. · may also be used for specific reversal of the central effects of benzodiazepines in drug or medicine overdose (return to spontaneous respiration and consciousness in order to render intubation unnecessary or allow extubation).

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - flumazenil 0.1 mg/ml - solution for injection - 1 mg/10ml - active: flumazenil 0.1 mg/ml excipient: acetic acid disodium edetate dihydrate nitrogen sodium chloride sodium hydroxide water for injection - flumazenil injection is indicated for reversal of the centrally sedative effects of benzodiazepines. it should therefore be used in anaesthesia and intensive care in the following indications: in anaesthesia · termination of general anaesthesia induced and maintained with benzodiazepines in inpatients. · reversal of benzodiazepine sedation in short diagnostic and therapeutic procedures in both inpatients and outpatients. · reversal of paradoxical reactions due to benzodiazepines. in intensive care and in the management of unconsciousness of unknown origin · for the diagnosis and/or management of benzodiazepine overdose due to self-poisoning or accidental overdose. · as a diagnostic measure in unconsciousness of unknown origin to differentiate between involvement of benzodiazepines, other medicines or drugs or brain damage. · may also be used for specific reversal of the central effects of benzodiazepines in drug or medicine overdose (return to spontaneous respiration and consciousness in order to render intubation unnecessary or allow extubation).

美国 - 英文 - NLM (National Library of Medicine)

akorn-strides, llc - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - injection - flumazenil injection, usp is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. flumazenil injection is indicated for the reversal of conscious sedation induced with benzodiazepines (see precautions: pediatric use ). flumazenil injection, usp is contraindicated: - in patients with a known hypersensitivity to flumazenil or benzodiazepines. - in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). - in patients who are showing signs of serious cyclic antidepressant overdose (see warnings ). flumazenil acts as a benzodiazepine antagonist, blocks the effects of benzodiazepines in animals and man, antagonizes benzodiazepine reinfo

美国 - 英文 - NLM (National Library of Medicine)

hf acquisition co. llc, dba healthfirst - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - flumazenil is contraindicated: in patients with a known hypersensitivity to flumazenil or benzodiazepines. in patients who have been given a benzodiazepine for control of a potentially life-threatening condition (e.g., control of intracranial pressure or status epilepticus). in patients who are showing signs of serious cyclic antidepressant overdose (see warnings). flumazenil acts as a benzodiazepine antagonist, blocks the effect of benzodiazepines in animals and man, antagonizes benzodiazepine reinforcement in animal models, produces dysphoria in normal subjects, and has had no reported abuse in foreign marketing. although flumazenil has a benzodiazepine-like structure it does not act as a benzodiazepine agonist in man and is not a controlled substance.

美国 - 英文 - NLM (National Library of Medicine)

mylan institutional llc - flumazenil (unii: 40p7xk9392) (flumazenil - unii:40p7xk9392) - flumazenil injection, usp is indicated for the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures, and for the management of benzodiazepine overdose. flumazenil  injection  is  indicated  for  the  reversal  of  conscious  sedation  induced with benzodiazepines (see precautions : pediatric use ). flumazenil injection, usp is contraindicated: flumazenil acts as a benzodiazepine antagonist, blocks the effects of benzodiazepines in animals and man, antagonizes benzodiazepine reinforcement in animal models, produces dysphoria in normal subjects, and has had no reported abuse in foreign marketing. although flumazenil has a benzodiazepine-like structure it does not act as a benzodiazepine agonist in man and is not a controlled substance.

比利时 - 英文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

b. braun melsungen ag - flumazenil 0,1 mg/ml - solution for injection - 0,1 mg/ml - flumazenil 0.1 mg/ml - flumazenil

比利时 - 英文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

b. braun melsungen ag - flumazenil 0,1 mg/ml - solution for injection - 0,1 mg/ml - flumazenil 0.1 mg/ml - flumazenil